Whitehawk director granted 38,040 stock options
Whitehawk Therapeutics director Baiteng Zhao received a grant of stock options as compensation.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Whitehawk Therapeutics director Baiteng Zhao received a grant of stock options as compensation. On the grant date, Zhao was awarded options for 38,040 shares of common stock at an exercise price of $4.16 per share, expiring on June 12, 2036. All options vest 100% after about one year or just before the next annual stockholder meeting, as long as Zhao continues serving the company.
Insider Trade Summary
Grant/Award: 38,040 shares
Grant/Award
1 txn
Insider
Zhao Baiteng
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 38,040 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 38,040 options (Direct)
Footnotes (1)
- F1. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2026.
Key Figures
Options granted: 38,040 options
Exercise price: $4.16 per share
Expiration date: June 12, 2036
+3 more
6 metrics
Options granted
38,040 options
Stock option grant to director Baiteng Zhao
Exercise price
$4.16 per share
Stock option strike price for the grant
Expiration date
June 12, 2036
Option term end for granted options
Underlying shares
38,040 shares
Common stock underlying the granted options
Post-grant derivative holdings
38,040 options
Total options held following the transaction
Vesting percentage
100% cliff vest
Vests in full after one year or before next annual meeting
Key Terms
Stock Option (right to buy), exercise price, 2021 Equity Incentive Plan, Service Provider, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "4.1600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
2021 Equity Incentive Plan financial
"as defined in the Issuer's 2021 Equity Incentive Plan"
Service Provider financial
"Subject to the Reporting Person continuing to be a Service Provider"
vest financial
"one hundred percent (100%) of the shares subject to the option shall vest"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Whitehawk Therapeutics (WHWK) report for Baiteng Zhao?
Whitehawk Therapeutics reported that director Baiteng Zhao received a grant of 38,040 stock options. These options give the right to buy common shares at $4.16 each as part of equity compensation, rather than an open-market purchase or sale.
What are the key terms of Baiteng Zhao’s stock option grant at Whitehawk (WHWK)?
Baiteng Zhao’s grant covers 38,040 stock options with an exercise price of $4.16 per share and an expiration date of June 12, 2036. Each option relates to one share of Whitehawk Therapeutics common stock under the company’s equity incentive plan.
When do Baiteng Zhao’s Whitehawk (WHWK) stock options vest?
The options vest 100% on the earlier of one year after the June 12, 2026 grant date or the day immediately before the next annual stockholder meeting. Vesting requires Zhao to continue as a service provider through the applicable vesting date.
Is Baiteng Zhao’s Form 4 transaction in WHWK stock a market buy or sell?
The Form 4 shows a grant of stock options, not a market buy or sell. The transaction is coded “A” for a grant or award acquisition, with a zero-dollar transaction price and a $4.16 per share exercise price for future potential share purchases.
How many Whitehawk (WHWK) derivative securities does Baiteng Zhao hold after this grant?
After this reported grant, Baiteng Zhao holds 38,040 derivative securities in the form of stock options. Each option is exercisable into one share of Whitehawk Therapeutics common stock, subject to the vesting conditions described in the equity incentive plan footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
